CliffBio
small molecule

MOXATAG

AMOXICILLIN

Loss of exclusivityMay 2027latest FDA-listed patent expiry
CompanyPragma →View the full company profile on CliffBio

Drug detail

Brand nameMOXATAG
Active ingredientAMOXICILLIN
Strength775MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2008
Marketing statusDISCN

Listed patents

PatentExpiresType
8299052May 2027use U-1304
8778924December 2026substance, product
8357394December 2026product

More from Pragma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

MOXATAG patent cliff — loss of exclusivity May 2027 | CliffBio